ATX — Amplia Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$16.57m
- AU$13.15m
- AU$1.15m
- 16
- 38
- 13
- 11
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -0.595 | -0.519 | -0.549 | -0.954 | -1.07 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.987 | -2.09 | -2.92 | -4.4 | -5.29 |
Capital Expenditures | -0.003 | 0 | -0.005 | -0.014 | -0.018 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | 0 | 0 | -0.012 | -0.041 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.003 | 0 | -0.005 | -0.027 | -0.058 |
Financing Cash Flow Items | -0.012 | -0.191 | -0.4 | -1.18 | -0.041 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.012 | 1.96 | 3.66 | 17.2 | -0.084 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.988 | -0.133 | 0.74 | 12.8 | -5.35 |